Dr. Reetuparna Acharya
Chandigarh University, Birla Institute of Technology, Mesra, Banasthali Vidyapith
About
A researcher and academician specializing in pharmacology with a strong foundation in anti-cancer drug development and preclinical studies. With a Ph.D. in Pharmaceutical Sciences from Birla Institute of Technology, Mesra, my research focuses on exploring novel pharmacological interventions against breast and liver cancers, particularly using azomethine and quinazoline derivatives. I have authored multiple peer-reviewed articles, contributed to book chapters with leading publishers like Elsevier and Bentham Science, and also a co-author of a textbook on molecular pharmacology.
A recipient of the prestigious ICMR-SRF fellowship, combined hands-on experience in in vivo cancer models with in silico molecular docking and bioinformatics techniques. Currently serving as an Assistant Professor at Chandigarh University with passion about drug discovery and translational research.
Employment
-
Chandigarh University Assistant Professor2025 - Present
Education
-
Birla Institute of Technology, Mesra Doctorate of Philosophy in Pharmaceutical Sciences and Technology2019 - 2024
-
Birla Institute of Technology, Mesra M. Pharmacy (Pharmacology)2016 - 2018
-
Banasthali Vidyapith B. Pharmacy2012 - 2016
Projects & Funding
Projects & funding information is unavailable.
Publications (11)
- The Substrate-Engine Model of Ferroptosis: Stage-Specific Targeting of Acyl-CoA Synthetase Long-Chain Family Member 4 and 5-Lipoxygenase in Alzheimer’s Disease Save
- Exploring the Antimicrobial Potential of Spirocyclic Compounds: A Comprehensive Review Save
- Contributors Save
- Extracellular vesicles as diagnostic biomarkers in cancer research Save
- An Azomethine Derivative, 1-(4-nitrophenyl)-N-phenylmethanimine (BCS2) Ameliorated 7,12-dimethylbenz(a)anthracene-induced Mammary Carcinoma through Nrf2-Keap1-HO-1 Pathway Save
- Harnessing Metabolism to Combat Neurodegeneration: Strategies for Reversing Age-Related Cognitive Decline Save
- An Azomethine Derivative, BCS3, Targets XIAP and cIAP1/2 to Arrest Breast Cancer Progression Through MDM2-p53 and Bcl-2-Caspase Signaling Modulation Save
- Naringin, a natural flavonone glycoside attenuates N-nitrosodiethylamine- induced hepatocellular carcinoma in sprague-dawley rats Save
- Small Molecules Polypharmacology for the Treatment of Breast Cancer: A Roadmap for the Future Chemotherapy Save
- Quinazolinone derivative BNUA‐3 ameliorated [NDEA+2‐AAF]‐induced liver carcinogenesis in SD rats by modulating AhR‐CYP1B1‐Nrf2‐Keap1 pathway Save